427 related articles for article (PubMed ID: 29313067)
1. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations.
Rivera-Del Valle N; Cheng T; Irwin ME; Donnella H; Singh MM; Chandra J
Cancer Chemother Pharmacol; 2018 Mar; 81(3):483-495. PubMed ID: 29313067
[TBL] [Abstract][Full Text] [Related]
2. Adaphostin cytoxicity in glioblastoma cells is ROS-dependent and is accompanied by upregulation of heme oxygenase-1.
Long J; Manchandia T; Ban K; Gao S; Miller C; Chandra J
Cancer Chemother Pharmacol; 2007 Mar; 59(4):527-35. PubMed ID: 16924499
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of platensic alcohol as an adamantane surrogate in antitumor drug lead adaphostin.
Wen Z; Duan Y; Xiong Y; Huang Y
Bioorg Med Chem Lett; 2021 Sep; 48():128270. PubMed ID: 34284106
[TBL] [Abstract][Full Text] [Related]
4. EZH2i EPZ-6438 and HDACi vorinostat synergize with ONC201/TIC10 to activate integrated stress response, DR5, reduce H3K27 methylation, ClpX and promote apoptosis of multiple tumor types including DIPG.
Zhang Y; Zhou L; Safran H; Borsuk R; Lulla R; Tapinos N; Seyhan AA; El-Deiry WS
Neoplasia; 2021 Aug; 23(8):792-810. PubMed ID: 34246076
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis identifies oxidative stress induction by adaphostin.
Stockwin LH; Bumke MA; Yu SX; Webb SP; Collins JR; Hollingshead MG; Newton DL
Clin Cancer Res; 2007 Jun; 13(12):3667-81. PubMed ID: 17575232
[TBL] [Abstract][Full Text] [Related]
6. Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines.
Bandolik JJ; Hamacher A; Schrenk C; Weishaupt R; Kassack MU
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234549
[TBL] [Abstract][Full Text] [Related]
7. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
LaBonte MJ; Wilson PM; Fazzone W; Groshen S; Lenz HJ; Ladner RD
BMC Med Genomics; 2009 Nov; 2():67. PubMed ID: 19948057
[TBL] [Abstract][Full Text] [Related]
8. Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells.
Wightman F; Lu HK; Solomon AE; Saleh S; Harman AN; Cunningham AL; Gray L; Churchill M; Cameron PU; Dear AE; Lewin SR
AIDS; 2013 Nov; 27(18):2853-62. PubMed ID: 24189584
[TBL] [Abstract][Full Text] [Related]
9. Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl.
Dasmahapatra G; Nguyen TK; Dent P; Grant S
Leuk Res; 2006 Oct; 30(10):1263-72. PubMed ID: 16481037
[TBL] [Abstract][Full Text] [Related]
10. Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine.
Shanafelt TD; Lee YK; Bone ND; Strege AK; Narayanan VL; Sausville EA; Geyer SM; Kaufmann SH; Kay NE
Blood; 2005 Mar; 105(5):2099-106. PubMed ID: 15388586
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process.
Yu C; Rahmani M; Almenara J; Sausville EA; Dent P; Grant S
Oncogene; 2004 Feb; 23(7):1364-76. PubMed ID: 14647418
[TBL] [Abstract][Full Text] [Related]
12. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
14. Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells.
Chen YJ; Wang JJ; Chang LS
Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):755-63. PubMed ID: 21824174
[TBL] [Abstract][Full Text] [Related]
15. The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism.
Dasmahapatra G; Rahmani M; Dent P; Grant S
Blood; 2006 Jan; 107(1):232-40. PubMed ID: 16166589
[TBL] [Abstract][Full Text] [Related]
16. Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.
Frys S; Simons Z; Hu Q; Barth MJ; Gu JJ; Mavis C; Skitzki J; Song L; Czuczman MS; Hernandez-Ilizaliturri FJ
Br J Haematol; 2015 May; 169(4):506-19. PubMed ID: 25712263
[TBL] [Abstract][Full Text] [Related]
17. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy.
Lu HK; Gray LR; Wightman F; Ellenberg P; Khoury G; Cheng WJ; Mota TM; Wesselingh S; Gorry PR; Cameron PU; Churchill MJ; Lewin SR
PLoS One; 2014; 9(11):e113341. PubMed ID: 25409334
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional profiling identifies altered intracellular labile iron homeostasis as a contributing factor to the toxicity of adaphostin: decreased vascular endothelial growth factor secretion is independent of hypoxia-inducible factor-1 regulation.
Hose C; Kaur G; Sausville EA; Monks A
Clin Cancer Res; 2005 Sep; 11(17):6370-81. PubMed ID: 16144942
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathway.
Yaseen A; Chen S; Hock S; Rosato R; Dent P; Dai Y; Grant S
Mol Pharmacol; 2012 Dec; 82(6):1030-41. PubMed ID: 22923501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
